This webinar will explore how the gut microbiome influences responses to cancer immunotherapy. We will discuss the latest research linking microbial composition in the gut to treatment outcomes for a variety of cancers and immunotherapies and discuss how these insights can be translated to new treatments.
You Will Learn:
- What bacteria are associated with response in cancer patients.
- The potential mechanisms of microbiome-mediated response.
- Current approaches to manipulate the microbiome, including diet, probiotics, and fecal microbiota transplantation.
By the end, attendees will gain a clear understanding of the microbiome’s role in cancer immunotherapy responses and its potential to improve patient outcomes through personalized interventions.